← FDA Drug Approvals (Drugs@FDA)

POTASSIUM CHLORIDE 20MEQ

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NEXUS · Approved 2021-03-18

Drug application

FDA Application #
ANDA214727
Application type
Abbreviated New Drug Application (Generic)
Brand name
POTASSIUM CHLORIDE 20MEQ
Generic name
POTASSIUM CHLORIDE
Active ingredients
POTASSIUM CHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
NEXUS
Manufacturer
Nexus Pharamaceuticals Inc.
First approval
2021-03-18

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown